Pfizer to Merge Off-Patent Unit With Mylan in All-Stock Deal

The video discusses Pfizer's strategy to improve its business by restructuring and focusing on innovative drug development. It highlights the company's efforts to manage debt and increase revenue through new products. The discussion also covers industry trends, such as the shift towards gene-based therapies, and the competitive landscape, including potential mergers and structural changes in other pharma companies like Johnson & Johnson.

What strategies are pharmaceutical companies employing to gain pricing power?

What challenges might Johnson and Johnson face regarding their business structure?